#Paris #France #Velico #veliPod #Blood Transfusion

A Revolutionary Step in Blood Transfusion

In a significant move that underscores the advancement of medical technology, the Armed Forces Blood Transfusion Centre (CTSA) in Paris heralded a new era with the installation of Velico's first veliPod™ on February 17, 2026. This innovative system represents a major leap forward in the decentralized manufacturing of spray-dried plasma, aiming to elevate the standards of trauma care and enhance preparedness in military and civilian settings alike.

The VeliPod™: A Game Changer

The veliPod™ is a modular production facility built within a standard shipping container, allowing the French military to produce spray-dried plasma on-site. This capability not only eliminates the need for traditional centralized production methods but also circumvents the cold chain logistics that often limit the accessibility of life-saving blood products in emergency situations. According to Dr. Jean-Jacques Lataillade, Chief Medical Officer at CTSA, the system is designed to operate using only water and electricity, making it exceptionally adaptable for various environments, including military bases.

Addressing Global Plasma Shortages

Uncontrolled bleeding remains one of the leading causes of preventable death in trauma cases. Conventional plasma relies heavily on refrigeration and meticulous handling, making it less accessible in critical situations. The FrontlineODP™ system embedded in the veliPod™ transforms liquid plasma into a stable, ultra-lightweight powder, which can be stored at room temperature and rehydrated in less than 2.5 minutes for transfusion. This innovation expands patient access, particularly in remote and emergency situations, thereby saving lives.

The demand for dried plasma currently exceeds supply, with global production capped at less than 50,000 units annually—far below the required levels for both civilians and military use. The deployment of the veliPod™ is anticipated to produce up to 9,000 units of spray-dried plasma per year, thus ensuring that nations can bolster their blood product reserves independently.

Enhancing National Preparedness

The significance of the veliPod™ extends beyond immediate medical applications; it embodies a strategic advance towards national self-sufficiency in medical resources. By establishing decentralized production capabilities, countries can enhance their preparedness for mass casualty events or natural disasters, ensuring rapid deployment to the areas most in need.

Richard Meehan, President and CEO of Velico, emphasized that this venture represents a critical achievement in combating global plasma shortages while setting a new standard for trauma care. With the French military’s commitment to this advanced technology, many predict wider adoption on a global scale, contributing to standardized medical practices across numerous countries.

Trailblazing Clinical Progress

The promising potential of Velico's FrontlineODP™ system has already been demonstrated in Phase I clinical trials, where the technology exhibited a robust safety profile without any serious adverse events. This signifies that the project not only holds immediate value for military personnel but could also lead to broader applications in civilian healthcare.

The installation of the first veliPod™ in Paris is merely the beginning of what is hoped to be a widespread shift in how blood products are manufactured and distributed. With plans for expanded offices and partnerships, Velico is positioned to lead the charge in the future of transfusion medicine.

Conclusion

In summary, Velico's introduction of the veliPod™ is a transformative development in the medical field. By marrying speed, mobility, and efficiency, it addresses a critical gap in the production of blood products. As nations face rising unpredictability in geopolitical situations, innovations like the veliPod™ ensure that military and emergency services remain equipped to save lives, fostering a more proactive approach to healthcare and emergency response across the globe.

For more information about Velico and their cutting-edge technology, visit www.veli.co.